RedHill Biopharma (RDHL) FCF Margin Growth (5y) (2017 - 2022)
RedHill Biopharma (RDHL) FCF Margin Growth (5y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 68,888.00 |
| Sep 30, 2022 | 65,613.00 |
| Jun 30, 2022 | 190,347.00 |
| Mar 31, 2022 | -20.65 Mn |
| Dec 31, 2021 | 1.01 Mn |
| Dec 31, 2020 | 855,103.00 |
| Jun 30, 2020 | 46.74 Mn |
| Dec 31, 2019 | 58.92 Mn |
| Sep 30, 2019 | -58,058.00 |
| Jun 30, 2019 | -66,048.00 |
| Mar 31, 2019 | -2.43 Bn |
| Dec 31, 2018 | 24.46 Mn |
| Sep 30, 2018 | 6.97 Mn |
| Jun 30, 2018 | 5.24 Mn |
| Dec 31, 2017 | 3.79 Mn |
| Sep 30, 2017 | 4.81 Mn |
| Jun 30, 2017 | 3.30 Mn |